Global Cardiac Aids Devices Market Outlook 2022

Cardiac assist equipment (CAD) is a mechanical pump that works with the heart to improve its pumping efficiency and maintain optimal blood flow throughout the body. Cardiac assist devices are used to treat advanced heart failure and are determined by individual needs. These designs are used to take over the function of the heart and help it function normally when it becomes weak. Cardiac assist devices are divided into three types: ventricular assist devices, intra-aortic balloon pump (IABP) and fully artificial heart. The ventricular assist device is implanted in the chest of the patient and consists of an electric motor and a power transmission system. It pumps blood through the heart to the entire body and has the power needed to distribute enough blood throughout the body. The intra-aortic balloon pump is an elongated, elongated balloon that controls the blood flow through the aorta of the largest blood vessel. The device expands and contacts according to the blood flow. When the heart beats, it becomes smaller so that blood can flow to other parts of the body. When the heart relaxes, it will become larger in order to retain more blood in the heart.

The global Cardiac Aids Devices market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Cardiac Aids Devices volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cardiac Aids Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Cardiac Aids Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Ventricular Assist Device
Full Artificial Heart
Intra-aortic Balloon Pump
Other

Segment by Application
Bridging Graft Therapy
Destination Treatment
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Evaheart
Abbott Laboratories
Abiomed
Terumo Corporation
Syncardia Systems
Getinge
Calon Cardio-Technology
Bivacor
Tokai Medical Products
Teleflex
Pulsecath
Berlin Heart GMBH

Frequently Asked Questions